Cite
HARVARD Citation
Vansteenkiste, J. et al. (n.d.). 14LBA Atezolizumab monotherapy vs docetaxel in 2L/3L non-small cell lung cancer: Primary analyses for efficacy, safety and predictive biomarkers from a randomized phase II study (POPLAR). European journal of cancer. 51 (3), pp. S716-S717. [Online].